Dapagliflozin tablets for diabetic patients have recorded annual sales of about $10.2 billion in the US for the 12 months ended February 2026.
Dapagliflozin tablets for diabetic patients have recorded annual sales of about $10.2 billion in the US for the 12 months ended February 2026.